fda semaglutide compounding news restricts non-approved compounded GLP-1 weight loss products FDA issues warning about some

Herein referred to as LSG

And the off-label extras you might be counting on, the heart data especially, belong to semaglutide, not to the new pill

More Excellent

Safety Considerations in Canine Subjects Available research suggests: Toxicity data: Limited long-term toxicology studies in dogs specifically Side effects: Research in rodents generally reports minimal adverse effects at studied doses Drug interactions: Potential interactions with other medications not well characterized Monitoring: No established protocols for monitoring dogs receiving BPC-157 The absence of comprehensive safety data in dogs represents a significant knowledge gap